Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wanzheng-brand Epimedium and Morinda officinalis Capsules
- Development stage
- Unknown
- Lead developer
- Guangzhou ImVin Pharmaceutical
- Administration
- Oral
01
Overview
Wanzheng-brand Epimedium and Morinda officinalis Capsules is an approved oral traditional Chinese medicine (TCM) herbal formulation developed by Imvin Pharma (Guangzhou Wanzheng Pharmaceutical Co., Ltd.). The product is a combination of extracts from two primary herbs: Epimedium (Herba Epimedii) and Morinda officinalis (Radix Morindae Officinalis). Traditionally used to tonify kidney yang and strengthen bones, it is indicated for conditions such as sexual dysfunction (impotence), fatigue, and age-related decline. The formulation contains bioactive compounds like icariin from Epimedium and various polysaccharides and glycosides from Morinda officinalis, which are thought to modulate androgen-related pathways and bone metabolism. It is classified as a health food/supplement in China.
- Brand names
- Wanzheng-brand Epimedium and Morinda officinalis Capsules万正牌淫羊藿巴戟天胶囊
- Other names
- Epimedium and Morinda officinalis Capsules
02
Targets
ESR1 (ERα)PDE5 (Phosphodiesterase 5A)AR (Adrenergic receptors)CYP3A4 (Cytochrome P450 3A4)ESR2 (ERβ)
Beyond the preview
Go deeper on Wanzheng-brand Epimedium and Morinda officinalis Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wanzheng-brand Epimedium and Morinda officinalis Capsules.